Söndag 14 December | 21:18:35 Europe / Stockholm

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-12-05 15:24:00

Pila Pharma is strengthening its scientific advisory board with a heavy hitter in metabolic research. The company has appointed Professor Thomas Lutz, a leading expert in obesity and the pancreatic hormone amylin, as a scientific adviser. The recruitment comes at a critical time as Pila Pharma approaches key preclinical proof-of-concept results for its candidate XEN-D0501.

Read the full article at biostock.se:
https://biostock.se/en/2025/12/pila-pharma-rekryterar-toppforskare-inom-fetma-som-vetenskaplig-radgivare/
This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se